Cancer research threatened by too much management and excessive regulation
15th January 2008
The fundamental ethos and creativity of cancer research is threatened by too much management and excessive regulation, says a Keynote Comment in The Lancet Oncology, January 2008 issue. The Comment also adds that there is a serious lack of regulation harmonization between countries, a recent blog reports.
Author Professor Richard Sullivan, London School of Economics and Political Science, London, UK and former Director of Clinical Programmes at Cancer Research UK, writes “For the past decade we have witnessed the inextricable rise of the business over-management of public-sector research and the layering of one set of regulations on another.”
He explains that Europe is laden with various directives which have added complex and sometimes contradictory regulation to cancer research. Few lessons have been learnt, says Sullivan, and European regulatory policymaking carries on failing.